| For: | Grubić Rotkvić P, Rotkvić L, Đuzel Čokljat A, Cigrovski Berković M. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure. World J Cardiol 2024; 16(8): 448-457 [PMID: 39221192 DOI: 10.4330/wjc.v16.i8.448] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i8/448.htm |
| Number | Citing Articles |
| 1 |
Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management. World Journal of Cardiology 2024; 16(12): 781-786 doi: 10.4330/wjc.v16.i12.781
|
| 2 |
Yi-Fei Zhang, Yu-Xiang Liu, Wu-Xiao Yang. Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure. World Journal of Cardiology 2025; 17(1): 100886 doi: 10.4330/wjc.v17.i1.100886
|
| 3 |
Luigi Falco, Emilio Di Lorenzo, Daniele Masarone. Shedding light on the effects of sodium-glucose cotransporter 2 inhibitors in the early stages of heart failure. World Journal of Cardiology 2025; 17(3): 102893 doi: 10.4330/wjc.v17.i3.102893
|
| 4 |
Larissa Dăniluc, Răzvan Dăniluc, Adela Benea, Alexandra-Iulia Lazăr-Höcher, Claudia Raluca Balasa Virzob, Mihaela-Diana Popa, Razvan Susan, Adina Braha, Adrian Apostol, Alexandra Sima, Lina Haj Ali, Loredana Suhov, Delia Hutanu, Mihaela Viviana Ivan. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Left Ventricular Global Longitudinal Strain in Adults with Type 2 Diabetes Mellitus: A Systematic Review. Journal of Clinical Medicine 2026; 15(13) doi: 10.3390/jcm15135137
|
| 5 |
Yan-Xi Zhang, Hai-Sheng Hu, Bao-Qing Sun. Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients. World Journal of Cardiology 2024; 16(10): 611-615 doi: 10.4330/wjc.v16.i10.611
|
| 6 |
Mohamed H Laimoud, Ismail R Raslan. Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure. World Journal of Cardiology 2024; 16(11): 665-668 doi: 10.4330/wjc.v16.i11.665
|
| 7 |
Panayotis K Vlachakis, Panagiotis Theofilis, Dimitris Tousoulis. SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat. World Journal of Cardiology 2024; 16(11): 669-672 doi: 10.4330/wjc.v16.i11.669
|